Additional electrodes on the Quartet™ LV lead provide more programmable pacing options than bipolar and tripolar equivalents
EP Europace Journal

Abstract
The aim of this study was to evaluate any benefits to the number of viable pacing vectors and maximal spatial coverage with quadripolar left ventricular (LV) leads when compared with tripolar and bipolar equivalents in patients receiving cardiac resynchronization therapy (CRT).
A meta-analysis of five previously published clinical trials involving the Quartet™ LV lead (St Jude Medical, St Paul, MN, USA) was performed to evaluate the number of viable pacing vectors defined as capture thresholds ≤2.5 V and no phrenic nerve stimulation and maximal spatial coverage of viable vectors in CRT patients at pre-discharge (
The Quartet lead with its four electrodes and the capability to pace from four anatomical locations provided the highest number of viable pacing vectors at pre-discharge and first follow-up visits, providing more flexibility in device programming and enabling continuation of CRT in more patients when compared with bipolar and tripolar equivalents.
Contributors

Johannes Sperzel
Author

Bernard Thibault
Author

Christopher A. Rinaldi
Author

Carlo Pappone
Author

Klaus-Jürgen Gutleben
Author

Christopher Leclercq
Author

Hedi Razavi
Author

Kyungmoo Ryu
Author

Luke C. Mcspadden
Author

Avi Fischer
Author

Gery Tomassoni
Author

